ABBV-181

· AbbVie

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABBV-181, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors [Phase 1]